Pictet Asset Management Holding SA
Position in VIR — Vir Biotechnology, Inc.
CIK 1993888
CAROUGE, V8
Position in VIR
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$13,268,218
+$13,186,886 QoQ
Shares Held
1,480,828
+10878.9% QoQ
Ownership
0.878%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pictet Asset Management Holding SA holds $3,316,428,809 across 130 Biotechnology names. VIR ranks #55 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
337,254 | $260,575,930 | |
| 2 | INSM |
INSMED Inc
|
1,102,248 | $180,239,592 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
337,569 | $150,738,061 | |
| 4 | ARGX |
Argenx SE
|
148,306 | $108,300,456 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,434,995 | $107,753,774 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
1,381,184 | $102,566,723 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
187,240 | $98,014,522 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
286,644 | $92,353,830 |
All Filings in VIR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,268,218 | 1,480,828 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $81,332 | 13,488 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $77,016 | 13,488 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $67,979 | 13,488 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $87,402 | 13,488 | Shares | Sole | 2025-05-05 | |
| No filing history on record for this holder in this stock. | ||||||